Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies

M Mofidfar, B Abdi, S Ahadian, E Mostafavi… - International journal of …, 2021 - Elsevier
Research in the development of ophthalmic drug formulations and innovative technologies
over the past few decades has been directed at improving the penetration of medications …

Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration

AH Jassim, DM Inman, CH Mitchell - Frontiers in pharmacology, 2021 - frontiersin.org
Mitochondrial dysfunction and excessive inflammatory responses are both sufficient to
induce pathology in age-dependent neurodegenerations. However, emerging evidence …

Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial

CG De Moraes, SWM John, PA Williams… - JAMA …, 2022 - jamanetwork.com
Importance Open-angle glaucoma may continue to progress despite significant lowering of
intraocular pressure (IOP). Preclinical research has suggested that enhancing mitochondrial …

[HTML][HTML] Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials

M Pfau, JK Jolly, Z Wu, J Denniss, EM Lad… - Progress in Retinal and …, 2021 - Elsevier
Fundus-controlled perimetry (FCP, also called 'microperimetry') allows for spatially-resolved
map** of visual sensitivity and measurement of fixation stability, both in clinical practice as …

Retinal energy metabolism in health and glaucoma

RJ Casson, G Chidlow, JG Crowston… - Progress in Retinal and …, 2021 - Elsevier
Energy metabolism refers to the processes by which life transfers energy to do cellular work.
The retina's relatively large energy demands make it vulnerable to energy insufficiency. In …

Cholinergic nervous system and glaucoma: From basic science to clinical applications

MA Faiq, G Wollstein, JS Schuman, KC Chan - Progress in retinal and eye …, 2019 - Elsevier
The cholinergic system has a crucial role to play in visual function. Although cholinergic
drugs have been a focus of attention as glaucoma medications for reducing eye pressure …

Glaucoma management in the era of artificial intelligence

SK Devalla, Z Liang, TH Pham, C Boote… - British Journal of …, 2020 - bjo.bmj.com
Glaucoma is a result of irreversible damage to the retinal ganglion cells. While an early
intervention could minimise the risk of vision loss in glaucoma, its asymptomatic nature …

Development and clinical deployment of a smartphone-based visual field deep learning system for glaucoma detection

F Li, D Song, H Chen, J **ong, X Li, H Zhong… - NPJ digital …, 2020 - nature.com
Abstract By 2040,~ 100 million people will have glaucoma. To date, there are a lack of high-
efficiency glaucoma diagnostic tools based on visual fields (VFs). Herein, we develop and …

Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma

A Bosco, SR Anderson, KT Breen, CO Romero… - Molecular Therapy, 2018 - cell.com
Dysregulation of the complement system is implicated in neurodegeneration, including
human and animal glaucoma. Optic nerve and retinal damage in glaucoma is preceded by …

Mechanisms contributing to inhibition of retinal ganglion cell death by cell permeable peptain-1 under glaucomatous stress

GA Johnson, B Kodati, RB Nahomi, JH Pham… - Cell Death …, 2024 - nature.com
This study assesses the neuroprotective potential of CPP-P1, a conjugate of an anti-
apoptotic peptain-1 (P1) and a cell-penetrating peptide (CPP) in in vitro, in vivo, and ex vivo …